|
Senior Scientist, Experimental Neuropathology
| Details |
Country: USA
Location: California-San Francisco South San Francisco, CA 94080
Total applied: 40 Job Category:Biotech/R&D/Science
Location:South San Francisco, CA 94080
Status:Full Time, Employee
Occupations:General/Other: R&D/Science;Pharmaceutical Research
Career Level:Experienced (Non-Manager)
|
|
Senior Scientist, Experimental Neuropathology
At Elan, we hold a fundamental belief that our science has the potential to improve patients’ lives. Our pipeline of developing compounds and investigative therapies reflects our commitment to bring innovative products to patients with unmet needs in the areas of neurodegenerative diseases, autoimmune diseases and severe pain.
Elan’s commitment to patients is reflected in all that we do: we are a company driven by the knowledge that our work is important and the desire to make a difference. Elan offers prospective employees exciting challenges, unique opportunities for career growth, and a fast-paced environment that emphasizes innovation and achievement.
Primary Objective of Position:
This position is part of an Experimental Neuropathology group dedicated to the development of novel therapeutics for chronic neurodegenerative disorders, including Alzheimer’s (AD) and Parkinson diseases (PD) and Multiple Sclerosis (MS).
Responsibilities:
Building a comprehensive human tissue bankIdentify and evaluate pathologies using proprietary reagents Cross-validation of tissue from animal modelsThe overall goal is the elucidation of disease mechanisms and novel target identification, achieved within an interactive, experimental setting
Requirements:
Ph.D. or MD with minimum 7 years experienceThe position requires an in-depth knowledge of neurodegenerative anatomy with extensive experience in the evaluation of PD, AD and MS brain tissue and neuroinflammatory lesionsAn extensive background in neuroanatomy, microscopy and histology are prerequisitesA working knowledge of in situ hybridization is highly desirableExperienced in the analysis of both human neurodegenerative disorders and induced and transgenic animal models of CNS diseases.Experience with quantitative image analysis is highly desirableWorks well in a group and team setting
|
| Related jobs |
|
|
Prialt Sales Training Manager
At Elan, we hold a fundamental belief that our science has the potential to improve patients’ lives. Our pipeline of developing compounds and investigative therapies ...
|
|
|
Senior Manager/Associate Director, Tax
At Elan, we hold a fundamental belief that our science has the potential to improve patients’ lives. Our pipeline of developing compounds and investigative therapies ...
|
|
|
IT Audit Manager
At Elan, we hold a fundamental belief that our science has the potential to improve patients' lives. Our pipeline of developing compounds and investigative ...
|
|
|
EH&S Specialist
At Elan, we hold a fundamental belief that our science has the potential to improve patients’ lives. Our pipeline of developing compounds and investigative ...
|
|
|
Systems Analyst
At Elan, we hold a fundamental belief that our science has the potential to improve patients’ lives. Our pipeline of developing compounds and investigative therapies ...
|
|
|
Senior IT Auditor - 457201KD
Senior IT Auditor Large Pharmaceutical Company – SF Bay Area $90k Responsibilities· Maintain an intermediate understanding of Sarbanes-Oxley ...
|
|
|
PRODUCT MANAGER / ASSOCIATE PRODUCT MANAGER / MARKETING MANAGER
Innovative, solutions oriented biotech company with vast growth and development potential is expanding its marketing team.Responsibilities: As a key member of the ...
|
|
|
Field Operations Coordinator
Are you looking for a career in a high-growth, profitable and fast-paced company that is truly making a difference in the future of healthcare? Look no further!&...
|
|
|
New Account Representative
Cbr Systems, the world's largest and most experienced stem cell bank, is seeking New Account Representatives for our Inside Sales team.
The Service
• We give ...
|
|
|
Senior Finance Manager - Manufacturing Operations
Title: San Francisco – Senior Finance Manager - Manufacturing Operations Salary$130-140k, plus bonus, options, etc.Responsibilities:In this role, you will help to ...
|
|
| Related press releases |
Courageous reform
There can be little doubt we are making progress when it comes to improving further education. More young people and adults than ever are gaining good qualifications ever...
|
|
Half of MG Rover workers want to return
Almost a year after the collapse of MG Rover, many former workers are paid less and wish they still worked for the firm, according to a report released today.
Of the nea...
|
|
Making ends meet
Earning some dosh to get through uni might seem unavoidable, but don't lose sight of the reason you are there: to get a degree. Earning shouldn't mean missing vital lectu...
|
|
|
|
The earth man cometh
I am merely the conduit,' says Patrick Holden, director of the Soil Association, when I ask him to sum up his achievement after 10 years in the job. 'The great thinkers, ...
|
|
Battle at the coalface
In his television review Rupert Smith described the NUM miners leader Arthur Scargill as "a ghastly little man who needed to be trodden on" (G2, March 23). I suppose he w...
|
|
Hutton eases small firms' pension fears
The government will not force employers to contribute to workers' pensions without making efforts to minimise the impact on firms, the work and pensions secretary, John H...
|
|
NHS hospital redundancies gather pace
A wave of redundancies across the NHS in England gathered force yesterday when a London teaching hospital announced that nearly 500 posts will be axed in an attempt to di...
|
|
Union warning over 'raw' stalls handlers
The Transport and General Workers Union (T&G) yesterday launched a fierce attack on the overall standard of the stalls handlers likely to be working at British racecourse...
|
|
Minimum wage to rise to £5.35
The minimum wage will rise by 6% in October to £5.35, the government confirmed yesterday, but it cautioned that the days of big, inflation-beating rises may be over...
|
|
|
|